Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Primary Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of antineoplaston therapy for hepatocellular carcinoma was terminated. No efficacy results are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Primary Liver Cancer | Phase 2 | Status: TERMINATED